MOAltria Group Inc.

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

William F. Gifford

Location

Virginia, USA

Exchange

NYSE

Website

https://altria.com

Summary

Altria Group, Inc.

Company Info

CEO

William F. Gifford

Location

Virginia, USA

Exchange

NYSE

Website

https://altria.com

Summary

Altria Group, Inc.

AI Insights for MO
5 min read

Quick Summary

Altria Group Inc. is a U.S.-focused tobacco and nicotine company headquartered in Richmond, Virginia. The company manufactures and sells smokeable tobacco products, oral tobacco products, and related nicotine products primarily in the United States. Its most important brand is Marlboro, which remains the leading cigarette brand in the U.S. market and is central to Altria’s revenue and cash flow. Altria also sells cigars and pipe tobacco under brands such as Black & Mild, and moist smokeless tobacco under brands such as Copenhagen, Skoal, Red Seal, and Husky. Its main customers are adult tobacco and nicotine consumers, while its commercial distribution depends on convenience stores, gas stations, wholesalers, and other retail channels that sell regulated tobacco products.

Strengths

•

Altria’s greatest strength is its ownership of Marlboro, the leading U.S. cigarette brand and one of the strongest consumer brands in tobacco.

•

The company has significant pricing power, which has helped it maintain profitability even as cigarette volumes decline.

•

Its operating profitability is high, as shown by the large operating income relative to revenue in the provided Q3 2026 data.

•

Altria also has a shareholder-friendly profile, with a high dividend yield and a history of returning cash to investors.

•

The business has relatively low market sensitivity, reflected in the provided beta of 0.461, which can make it attractive to defensive and income-oriented investors.

Key Risks

•

Altria faces significant regulatory risk because tobacco and nicotine products are closely monitored by the FDA and other government authorities.

•

New restrictions on flavors, nicotine levels, marketing, packaging, or product authorization could harm sales and limit growth in both legacy and newer categories.

•

Litigation and public-health challenges remain persistent risks, especially for products that claim or imply reduced harm.

•

The company also faces the structural risk of declining cigarette consumption, which could eventually overwhelm the benefit of price increases.

What to Watch

The most recent period in the supplied data is Q3 2026, during which Altria reported total revenue of about $6.11 billion and operating income of about $3.14 billion.
Net income was about $2.30 billion, and both basic and diluted EPS were listed at $1.37.
The data indicate strong profitability, with gross profit of about $3.82 billion and operating income representing a large portion of revenue.
The company continued to be valued primarily as a mature cash-flow and dividend stock, with a market capitalization of about $119.49 billion and a dividend yield near 6.0 percent in the dataset.
Recent news also emphasized ongoing investor attention on cigarette price increases, declining cigarette volumes, and the strategic need to grow in reduced-risk or smoke-free products.
Another important industry event was Philip Morris seeking to launch IQOS in the U.S., which could affect Altria’s competitive environment even though the approval timeline remains uncertain.

Price Drivers

•

Altria’s stock price is heavily driven by the durability of its cash flow from Marlboro and other tobacco brands.

•

Investors focus on whether price increases can continue to offset declining cigarette volumes, because the company’s core cigarette business is shrinking over time.

•

Dividend yield is another major price driver, as Altria is widely owned by income-focused investors and currently shows a high dividend yield based on the provided data.

•

Valuation also matters, with the stock trading at a price-to-earnings ratio of about 15 and an earnings yield of about 6.7 percent in the supplied metrics.

•

Regulatory developments, litigation, FDA decisions, taxation, and competition from smoke-free nicotine products can all move the stock because they affect long-term earnings visibility.

•

Market sentiment is also influenced by whether investors believe Altria can build meaningful growth from oral nicotine, vapor, and other non-combustible products.

Recent News

•

Recent news coverage highlights the tension between Altria’s strong dividend profile and the long-term decline of its core cigarette business.

•

Articles describe Altria as a high-yield income stock with powerful brands, but also note that nearly all revenue remains tied to tobacco and especially Marlboro.

•

Philip Morris has been seeking to bring IQOS to the U.S. after buying Altria’s rights and resolving a patent dispute with British American Tobacco, while health groups have urged the FDA to block approval.

•

Analysts and commentators continue to compare Altria with Philip Morris and British American Tobacco, often concluding that Philip Morris has stronger long-term growth because of IQOS, ZYN, and global smoke-free momentum.

•

Some coverage has praised Altria’s pricing power and ability to offset volume declines through cigarette price hikes.

•

Other coverage remains cautious because past diversification moves such as Juul, Cronos, and NJOY have involved setbacks, write-offs, legal issues, or execution uncertainty.

Market Trends

•

The broader tobacco market is being shaped by declining cigarette consumption, rising regulation, and consumer migration toward smoke-free nicotine products.

•

Traditional cigarette companies are using price increases, cost controls, and dividends to sustain shareholder returns while volumes fall.

•

At the same time, heated tobacco, vapor, and oral nicotine pouches are becoming more important because they offer potential growth in a mature and pressured industry.

•

Regulators and public-health groups remain skeptical of reduced-risk claims, so product authorization and marketing rules are critical industry drivers.

•

Large tobacco companies with strong smoke-free portfolios, such as Philip Morris, are increasingly viewed as better positioned for long-term growth than companies more dependent on cigarettes.

•

Income investors continue to value high dividends in the sector, but high yields can also signal concern about regulatory pressure, litigation, and business-model transition risk.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on MO

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

avatar
@ShallowLoving 1 month ago

Altria (MO) offers a 6% yield and 13x forward earnings for income portfolios

Altria (MO) offers a 6% yield and 13x forward earnings for income portfolios

post thumbnail
avatar
@starcahier 7 months ago

Nasdaq drops into correction territory as oil tops $110

Nasdaq drops into correction territory as oil tops $110

post thumbnail
avatar
@kewur 8 months ago

Overview of 4 dividend stocks handling oil volatility (PSX, MO, CVX, XOM)

Overview of 4 dividend stocks handling oil volatility (PSX, MO, CVX, XOM)

post thumbnail
avatar
@Deep_Brief438 10 months ago

MO Still Attracts Income Investors

MO Still Attracts Income Investors

Fueled by reliable payouts, Altria still draws investors who want income. Even so, its main operations carry risks that won’t vanish soon. Shareholder rewards stay front of mind, dividends, stock reductions guide decisions. Growth isn’t part of the pitch here. Yet stability often outweighs flash when earning matters most.

avatar
@Curlar 10 months ago

If an unethical portfolio doesn’t bother you

If an unethical portfolio doesn’t bother you

For those who don’t really give a hoot lol.
I wanna try this experiment where I build an investment portfolio thats basically just the most unethical companies I can find and see if it actually beats the market or whatever. Heres what I got so far

Oil n gas:
- Exxon Mobil - one of the biggest oil companies out there, Chevron

Gambling:
Flutter Entertainment - owns Fanduel, MGM Resorts , more focused on the in-person gambling in Vegas

Defence/Weapons:
- Lockheed Martin - makes F35s, RTX Corp , Lockheed Martins direct competitor

Tobacco & Nicotine:
- Phillip Morris , Altria
ny other players youd suggest or throw in

avatar
@kewur 1 year ago

3 High-Yield Dividend Stocks for Retirees Seeking Stability

3 High-Yield Dividend Stocks for Retirees Seeking Stability

post thumbnail
avatar
@kewur 1 year ago

Earnings Season Kicks Off Strong as Big Tech and AI Drive Market Performance

Earnings Season Kicks Off Strong as Big Tech and AI Drive Market Performance

post thumbnail
avatar
@kewur 1 year ago

CDs Are Losing Their Appeal as Interest Rates Drop

CDs Are Losing Their Appeal as Interest Rates Drop

post thumbnail
avatar
@kewur 1 year ago

Why Opening a New CD Might Not Be a Good Move Right Now

Why Opening a New CD Might Not Be a Good Move Right Now

post thumbnail
avatar
@kewur 1 year ago

Altria's High Dividend Yield Comes With Risks

Altria's High Dividend Yield Comes With Risks

post thumbnail